Cardiovascular outcomes During accumulated follow-up time totaling approximately 39.0 person-years, three expanded MACE events were observed, yielding an incidence rate of 7.69 events per 100 person-years
A healthcare provider will evaluate your health status, determine if you need B12 supplementation, and prescribe the correct dosage and injection frequency
For non-diabetic adults seeking pharmacologic support for weight management, weekly semaglutide achieves markedly superior weight reduction compared with daily liraglutide over 68 weeks, without new safety concerns
Clinical trial data In the STEP 1 clinical trials published in the New England Journal of Medicine (NEJM) in 2021, 1,961 participants without type 2 diabetes received semaglutide 2.4 mg once weekly, along with lifestyle modifications
Meanwhile, quitting smoking is associated with a substantial reduction in the risk of cardiovascular disease, with the benefits becoming evident within the first five years after cessation